Race and the Personalization of Medicine | GenomeWeb

One of the current stand-ins for personalized medicine is ethnicity, as people with different ancestral backgrounds can have varying risks for disease. However, a recent study led by researchers at Mount Sinai School of Medicine in New York found that "in the genomic era, conventional racial/ethnic labels are of little value" when translated to the clinic.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.